Clinical trial
AVACEN Treatment Method on Fasting and Postprandial Blood Glucose
NCT04018586 is registered in ClinicalTrials.gov with Jeff Moore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AVACEN Treatment Method on Fasting and Postprandial Blood Glucose
- Lead sponsor
- Jeff Moore
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2019
- Completion date
- September 15, 2019
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.